Fundraising FoxBoulder Ventures — 2022 Investments
2 investments dated 2022 · listed companies and verified rows first · show all
Mineralys Therapeutics is a clinical-stage pharmaceutical company developing lorundrostat, a treatment targeting dysregulated aldosterone.
BiotechHealthtechRadnor, US
Eric Warren(Chief Commercial Officer)inAlex Gold(Chief Medical Officer)inAdam Levy(Executive Officer)Alexander Asam(Director)
BoardBrian Taylor Slingsby(Founder & former CEO / Board Director)Olivier Litzka(Director)in
Co-investorsAndera PartnersCatalys PacificHBM Healthcare InvestmentsHBM PartnersSamsara BioCapitalSR One Capital Management+3 more
RapidFort provides a software supply chain security platform that analyzes and hardens container images to eliminate vulnerabilities and reduce attack surface across development and production environments.
Cloud ComputingCybersecurityDeveloper ToolsSunnyvale, US
Mehran Farimani(Founder)inRuss Andersson(Founder)inRajeev Thakur(Founder)inGeorge Manuelian(Founder)inRajeev T(Founder)
BoardRobert Mee(Director)
Co-investorsForgePoint CapitalAlumni VenturesBloomberg BetaCheyenne VenturesDelta-v CapitalEvolution Ventures+9 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.